DIAsource ImmunoAssays S.A.
ActiveSummary
DIAsource ImmunoAssays S.A. has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4.4m and a net result of -€1.1m. Equity has been stable since 2018 (±1.7% per year). Its solvency ranks better than 38% of 783 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Official details
Source: KBO- Status
- Active since 23-05-1996 Normal situation
- Activity
- Medical imaging and medical laboratories NACE 86910and 1 other
- Joint committee
- 207 Paritair Comité voor de bedienden uit de scheikundige nijverheid · annual accounts 2025
- Establishment unit
- 2.076.774.156 1348 Ottignies-Louvain-la-Neuve, since 21-04-1998
- Financial year end
- 31 December
- Peppol
- Reachable since 05-01-2026
Board and ownership
- Michal KOSTKADirector · since 05-09-2017
- de Borman BéatriceDirector · since 03-04-2020
- Matej MILATADirector · since 22-08-2023
- Auditor
- RSM Belgium InterAudit BV-SRL
- BIOVENDOR BELGIUM99%2022 annual accounts of BIOVENDOR BELGIUM
- BIOVENDOR - LABORATORNI MEDICINA ASconsolidatesannual accounts 2025
- Holdings
- Shares in 1 company DIAsource Iberia
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Turnover
- €16.7m
- ▼ 4.2%
- Loss
- €1.1m
- Equity
- €4.4m
- ▼ 19.7%
- Total assets
- €10.1m
- ▼ 12.9%
- Employees on 31-12-2025
- 79
- ▼ 10.2%
Score breakdownraises riskLoss of €1.1m (financial year 2025)Liquidity: current ratio 1.53, cash €407,712Size: turnover €16.7m, 80.9 FTE, total assets €10.1mlowers riskSector: Human health activities (NACE 86)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, medium-sized). It does better than 44% of them on solvency, 19% on liquidity, 15% on profitability and 15% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 69 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Appointment: RSM Belgium InterAudit BV-SRL (statutory auditor)
- · Gazette deed Resignation: Ondrej PALAT (director)Appointment: Matej MILATA (director)
- · Gazette deed Appointment: RSM Belgium InterAudit BV-SRL (statutory auditor)
Comparable companies
These companies have the same main activity as DIAsource ImmunoAssays S.A.: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €7.1m and €13m, founded between 1984 and 2005.
| Company | Total assets | Turnover |
|---|---|---|
| DIAsource ImmunoAssays S.A. Ottignies-Louvain-la-Neuve | €10.1m | €16.7m |
| LKO -LMC Sint-Truiden | €11.1m | €22.1m |
| Algemeen Medisch Laboratorium WEST Ardooie | €11.4m | €19.6m |
| ALGEMEEN KLINISCH LABO Lier | €7.1m | €15.5m |
| LABORATORIUM M. NUYTINCK Evergem | €12.6m | €24.5m |
| Laboratoires réunis Fléron | €7.7m | €15.2m |
| MEDPACE BELGIUM Leuven | €8.9m | €21.6m |
Key facts about DIAsource ImmunoAssays S.A.
- What is the company number of DIAsource ImmunoAssays S.A.?
- The company number of DIAsource ImmunoAssays S.A. is 0457.934.723. The VAT number is the same number with BE in front: BE 0457.934.723.
- Where is DIAsource ImmunoAssays S.A. based?
- The registered office is at Rue du Bosquet 2, 1348 Ottignies-Louvain-la-Neuve.Company details
- What does DIAsource ImmunoAssays S.A. do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of DIAsource ImmunoAssays S.A.?
- The legal form of DIAsource ImmunoAssays S.A. is Public limited company (NV).
- When was DIAsource ImmunoAssays S.A. founded?
- DIAsource ImmunoAssays S.A. was founded on 23-05-1996.
- Is DIAsource ImmunoAssays S.A. still active?
- Yes, DIAsource ImmunoAssays S.A. is an active enterprise in the KBO register.
- How many employees does DIAsource ImmunoAssays S.A. have?
- DIAsource ImmunoAssays S.A. had an average of 80.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does DIAsource ImmunoAssays S.A. fall under?
- In its 2025 annual accounts, DIAsource ImmunoAssays S.A. states joint committee 207 (Paritair Comité voor de bedienden uit de scheikundige nijverheid).
- What is the turnover of DIAsource ImmunoAssays S.A.?
- The turnover of DIAsource ImmunoAssays S.A. was €16.7m in financial year 2025, according to the filed annual accounts.
- Is DIAsource ImmunoAssays S.A. profitable?
- In financial year 2025, DIAsource ImmunoAssays S.A. made a loss of €1.1m.
- Where can I find the annual accounts of DIAsource ImmunoAssays S.A.?
- DIAsource ImmunoAssays S.A. filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DIAsource ImmunoAssays S.A. due?
- DIAsource ImmunoAssays S.A. must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.